In a report released today, Hassan Al-Wakeel from Barclays maintained a Hold rating on Smith & Nephew (SN – Research Report), with a ...

Embattled hip and knee implant maker Smith & Nephew has hit back at a report claiming that it deployed aggressive accounting ...

Patented technology further personalizes total knee arthroplasty for surgeons and patientsSmith+Nephew (LSE:SN, NYSE:SNN), ...

GAMMA Investing LLC boosted its position in Smith & Nephew plc (NYSE:SNN – Free Report) by 160.0% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,257 ...

Heartland Advisors, an investment management company, released its “Heartland Mid Cap Value Fund” third quarter 2024 investor ...

Smith+Nephew announced today that it signed a co-marketing agreement with JointVue for its OrthoSonic ultrasound device.

Smith+Nephew (LSE: SN, NYSE: SNN), the global medical technology company, is proud to announce that its RENASYS EDGE Negative ...

Smith & Nephew (LSE:SN.) is navigating a dynamic period marked by both opportunities and challenges. Recent highlights include a notable 31.2% increase in dividend payouts and innovative product ...

Patented technology further personalizes total knee arthroplasty for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it has signed a ...

Local leaders have expressed their delight at the company's revised plan to keep its Hull site open and build a new facility ...

On Monday, RBC Capital maintained its optimistic outlook on Smith & Nephew PLC (LON:SN:LN) (NYSE: SNN), reiterating its Outperform rating and a price target of £15.00. The firm's stance is based ...

Smith & Newphew is one of the world’s largest hip replacement manufacturers Embattled hip and knee implant maker Smith & Nephew has hit back at a report claiming that it deployed aggressive ...